Current Primary Outcome Measures •Number of participants that receive 2 doses of dexamethasone per protocol. [ Time Frame: Intervention: 72 hours; Follow-up: 30 days ] -- A total of N=30 recruited ...

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Bronchiolitis ...

A new study at Intermountain Primary Children's Hospital in Salt Lake City and led by faculty at University of Utah Health has found that follow-up appointments for hospitalized children treated for ...

Please provide your email address to receive an email when new articles are posted on . There was a 75.3% rise in bronchiolitis admissions in 2022 to 2023 compared with the median before COVID-19.

A newly developed primary care clinical pathway for bronchiolitis management in young children successfully reduced bronchodilator and steroid use.

Please provide your email address to receive an email when new articles are posted on . Long-term outcomes of bronchiolitis in infancy include a higher prevalence of asthma and more obstructive lung ...

A new national trial will aim to determine the most effective breathing support for babies hospitalized with bronchiolitis. Bronchiolitis is a viral chest infection that affects babies and children ...

WellSpan Pediatric Medicine practices are reporting viral upper respiratory infections and the stomach flu this week. In both cases, hand washing is the most effective way to prevent the spread. This ...

EN ESPAÑOL: Prevenir ell virus sincitial respiratorio (VSR) es la mejor manera de mantener a los bebés a salvo de la bronquiolitis A common cause of winter sniffles, sneezes, runny noses and coughs is ...

Bronchiolitis is defined as an acute inflammation of bronchioles in the lower respiratory tract that results in airway obstruction with accompanying progressive dyspnea and poor feeding. This ...

DelveInsight’s Bronchiolitis Obliterans Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, bronchiolitis obliterans syndrome emerging drugs, market ...